Medtimo announced that it has filed a patent infringement complaint in the U.S. District Court of the District of Delaware against Allurion Technologies (ALUR). The complaint alleges that Allurion’s gastric balloon system infringes upon three key Medtimo patents. The company stated this action follows Allurion’s recent unsuccessful challenge of Medtimo’s patent rights in the U.S. Patent and Trademark Office.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALUR:
- Allurion Technologies’ Earnings Call: Strategic Shift Amid Revenue Challenges
- Eight option delistings on August 18th
- Allurion Technologies Delays Q2 2025 Financial Filing
- Allurion Technologies Shifts Strategy Amid Q2 Earnings
- Strategic Realignment and Financial Management Drive Buy Rating for Allurion Technologies